Antibodies to laminin in Chagas' disease by unknown
ANTIBODIES  TO  LAMININ  IN  CHAGAS'  DISEASE* 
BY ANA  SZARFMAN, VICTOR  P.  TERRANOVA, STEPHEN  I.  RENNARD, 
JEAN-MICHEL  FOIDART, MARIA DE  FATIMA LIMA, JON  I.  SCHEINMAN, 
AND GEORGE  R.  MARTIN 
From the Laboratory of Developmental Biology and Anomalies, National Institute of Dental Research, 
National Institutes of Health, Bethesda, Maryland 20205;  Transplantation Research Branch, Casualty 
Care Research Program Center, Naval Medical Research Institute, Bethesda, Maryland 20814; Instituto de 
Microbiologia, Universidade Federal de Rio de Janeiro, Ilha do Funddo, Rio de Janeiro 21910,  Brazi# and 
Department of Pediatrics, University of Minnesota, Minneapolis 55455 
Chagas' disease occurs in Central and South America in individuals infected with 
the  protozoan  Trypanosoma  cruzL  In  the  acute  stage  of  the  disease,  subcutaneous 
swelling around the eye (chagoma), myocarditis, encephalitis, and fever are observed. 
These conditions are related to the invasion of the tissues by the parasite (1). Years 
later, in the chronic stage of Chaga  s' disease, when  few, if any, parasites are present 
in the tissues, inflammatory, degenerative, and fibrotic changes are observed, partic- 
ularly in  the endocardium,  myocardium,  esophagus,  and  colon  (1,  2).  Such  lesions 
can be life threatening (1). 
Immunological causes are thought to underlie the chronic lesions in Chagas' disase 
(3).  Sera from  both acute and chronic cases of Chagas' disease show reactivity with 
the parasite as well as with normal endocardium, blood vessels, and the interstitium 
of striated muscle  (the  so-called EVI 1 pattern),  and  Schwann  sheaths of peripheral 
nerve  (4-6).  Studies on  skeletal muscle biopsies of individuals infected with  T.  cruzi 
indicate the existence of immunoglobulins  (Ig)  with  a  similar distribution  (4).  The 
extent  of the clinical alterations  found  in  individuals with  chronic Chagas'  disease 
was  correlated  with  these  tissue-reacting  antibodies  in  one  (4)  but  not  in  other 
geographical areas  (7).  These  antibodies were  not  found  to occur  in  various other 
heart  diseases examined  (4).  Here,  we demonstrate  that  these antibodies react with 
connective tissue structures. We also have assayed purified components of connective 
tissues  for  their  reaction  with  the  antibodies  present  in  humans  and  in  Rhesus 
monkeys infected with  T. cruzi.  Our studies indicate that these antibodies are specific 
for laminin (8), a  basement membrane glycoprotein, which mediates the attachment 
* Supported in part by funds provided by the Brazilian Research Council  (CNPq), Financiadora de 
Estudos e Projectos (FINEP), Brazil; the United Nations Development  Programme  World Bank/WHO 
special program for research and training in tropical diseases; and research task MF58.524.013.1031 from 
the Naval Medical Research and Development Command.  The opinions and assertions contained herein 
are the private ones of the writers and are not to be construed as official or reflecting the views of the Navy 
Department of the naval service at large. The experiments reported herein were conducted  according to 
the principles set forth in the current edition of the "Guide for the Care and Use of Laboratory Animals," 
Institute of Laboratory Animal Resources, National Research Council. 
1  Abbreviations used in this paper: ANA, antinuclear antibodies; CHO, chinese hamster ovary; EHS 
tumor,  Engelbreth-Holm-Swarm  tumor;  ELISA, enzyme-linked immunoabsorbent  assay; EVI, endocar- 
dium,  blood vessels and interstitium;  FN,  fibroneetin;  IF, immunofluorescence;  LIT, ox liver-infusion 
tryptose;  PBS, phosphate-buffered  saline;  pepsin  fragments  of laminin: PI, Mr ~  285,000; Pli, Mr -~ 
272,000; Pb, Mr =  70,000; Pc, Mr ~ 52,000. 
Journal of Experimental Medicine • Volume 155 April 1982  1161-1171  1 161 1162  ANTIBODIES TO  LAMININ  IN  CHAGAS' DISEASE 
of epithelial and endothelial cells to type IV collagen (9). 
Materials  and  Methods 
Patients.  Sera were examined from nine patients, ages  18-40, with chronic Chagas' disease 
(five with cardiomegaly and three with megacolon) in whom the infection had been present for 
at least 5 yr (mean 7 yr). In addition, sera were studied from six patients between the ages of 
3 mo and 4 yr in whom acute Chagas' disease was present. Each child had unilateral chagoma 
of the eye and acute myocarditis within the last  2  mo, and the diagnosis was confirmed by 
identifying parasites in blood smears. All patients had a  positive serology (titers _>1:64) for T. 
cruzi  by the  indirect immunofluorescence (IF)  test  using cultured epimastigote  forms  of the 
parasite  (Tulahuen strain)  (10).  Sera of 20 normal individuals and  10 patients with inflam- 
matory diseases other than Chagas' disease (3 with osteomyelitis, 4 with paracoccidioidomycosis, 
and 4 with bacterial meningitis) from the same geographical areas (Argentina and Brazil), all 
showed a negative reaction for T. cruzi (10). Additional negative controls included sera from 10 
patients with  surgical  wounds and  10  with  invasive neoplasms of the  breast  and  digestive 
system, 10 with toxoplasmosis,  10 with rheumatoid arthritis, and 10 with malaria, all from the 
United States. 
Infected Monkeys.  The insect Dzpetalogaster  maximus, infected 3 mo earlier with blood from an 
acute case of Chagas' disease, was kindly supplied by Dr.  P. Marsden from the University of 
Brasilia,  Brasilia,  Brazil.  Two  Rhesus  monkeys were  infected  under  the  eyelid  with  1,000 
metacyclic trypomastigotes obtained from the feces of the insect. After infection of the monkey, 
T.  cruzi trypomastigotes were observed in blood smears, and  1 mo after infection the animals 
were found to have developed antibodies against the parasite (titer ___ 1:64)  (10). 
Parasites.  Human foreskin fibroblasts strain CRL 1475 (kindly provided by Dr. W. Gleiber, 
National Institutes of Health),  which  do  not synthesize laminin, were  grown in Dulbecco's 
modified Eagle's medium (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) 
with 4% fetal calf serum (Gibco Laboratories). When confluent, cells were infected with blood 
trypomastigote forms of T. cruzi, Tulahuen strain (kindly provided by Dr. T. Mercado, National 
Institutes  of  Health).  The  amastigote  and  trypomastigote  stages  were  obtained  from  the 
supernatant fluids from cultures 5 d  after infection. Epimastigotes were cultured in ox liver- 
infusion tryptose (LIT) medium pH 7.2 as described (11). Blood trypomastigotes were purified 
as described  (12).  The parasites were  fixed with 0.5%  paraformaldehyde,  allowed to  dry on 
slides, and used as antigens in an indirect IF test  (10).  The purified antibodies were used at a 
concentration of 50 /tg/ml.  The  unbound fraction  was  reconstituted  to  the  original serum 
volume and used diluted 1:10. 
Laminin.  Laminin was extracted from the Engelbreth-Holm-Swarm (EHS) tumor grown in 
C57 BI mice and was isolated as previously described (8). For additional purification, 10 mg of 
laminin, dissolved in 1 ml of 8 M  urea, 0.05 M  Tris-HCl, pH 8.6, was applied to a column of 
DEAE-cellulose (2.5  X  25 era)  and eluted with a  gradient of 0-0.3 M  NaCI.  Portions of the 
collected fractions were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis 
or tested as antigen in an enzyme-linked immunoabsorbent assay (ELISA)  (sera were diluted 
1:50, and purified antibodies were used at 50/~g/ml) (see below). Various fragments of mouse 
laminin (PI from soluble laminin and Pli, Pb, and Pc from insoluble laminin), obtained from 
laminin  by  digestion  with  pepsin  (Boehringer,  Federal  Republic  of  Germany)  (20  mg/g 
laminin), were a gift from Dr. Rupert Timpl, Max Planck Institut fiir Biochemie, Martinsried, 
Federal Republic of Germany (13).  Laminin was also tested after reaction with an equal weight 
of trypsin and Streptomyces griseus  protease (Sigma Chemical Co., St. Louis, MO). Each of these 
antigens were tested at a concentration of 500 ng of antigen per well. 
Gel  electrophoresis  of the  protein  precipitated  by  serum  from  either  control  or  infected 
monkeys, or of the affinity-purified antibodies, was carried out as described (8).  Rabbits and 
sheep were immunized with laminin as previously described (8). The sera obtained from these 
animals, as  well  as sera  from  monkeys infected  with  T.  cruzi,  were  chromatographed  on  a 
column of laminin-Sepharose (8). Unbound material was washed from the column with 0.02 M 
phosphate-buffered  saline  (PBS),  pH  7.4,  and  the  bound  material  containing the  affinity- 
purified  antibodies was  eluted  with  0.5  M  NaCI,  0.5  M  acetic  acid,  pH  3.  The  fractions SZARFMAN ET  AL.  1163 
containing  protein  were  adjusted  to  pH  7,  dialyzed  against  PBS,  and  concentrated  by 
uhrafihration. 
Immunoassays.  Indirect  IF  (4)  was  used  to  test  the  reaction of antibodies obtained  from 
humans and monkeys with freshly prepared cryostat sections of mouse peripheral nerve, skin, 
kidney, heart, and the EHS mouse tumor. The protease inhibitors p-hydroxymercuribenzoate 
(50 #g/ml) and phenylmethylsulfonyl fluoride (50 #g/ml)  (Sigma Chemical Co.) were present 
during all steps of the reaction. In some experiments, the same section was exposed first to 
antibodies from infected monkeys purified by laminin-Sepharose affinity chromatography (50 
#g/ml) and then to antilaminin antibodies purified from rabbit serum (50 #g/ml). The tissue 
distribution of these antibodies was established with species-specific secondary fluorochromes 
(rhodamine conjugated goat anti-human IgG and fluorescein conjugated goat antirabbit IgG) 
(N. L. Cappel Laboratories, Inc., Cochranville, PA). 
Attempts were made to identify masked antigens by treating the tissue sections for 3 h with 
chondroitinase ABC (50 U/ml) (Miles Laboratories, Elkhart, IN) (14), testicular hyaluronidase 
(40 mg/ml) (Type IV, Sigma Chemical Co.), or purified bacterial collagenase form III (500 U/ 
ml), Advance Biofactures, Lynbrook, NY)  (15) before reaction with antibodies. 
The blocking reaction with collagen types I, III, IV, or V, fibronectin (FN), BM-1  proteo- 
glycan, chondronectin, laminin, or bovine serum albumin was performed at antigen concentra- 
tions of 150 btg/ml for  1 h  at 37°C and overnight at 4°C.  The antigens used were obtained 
from the following sources: type I collagen from lathyritic rat skin (16), type III collagen from 
a pepsin digest of fetal calf serum (17), type IV collagen from the EHS tumor (18), type V  (cr- 
AB) from calf skin (19), FN from mouse serum (20), BM-1 proteoglycan from the EHS tumor 
(21),  and  chondroneein  from  chicken  serum  (22).  When  one  of these  materials  inhibited 
fluorescence, a titer was obtained by absorbing the sera with different concentrations of antigen. 
The  reactivity of sera  from  humans  or Rhesus  monkeys  infected with  T.  cruzi with  these 
components of connective tissue and laminin fragments (see above) were also tested by ELISA, 
using a concentration of 500 ng of antigen per well (23). 
The class of antibodies reacting with parasites tissue sections or laminin was assessed by 
immunofluorescence or by ELISA using fluorescein or peroxidase-conjugated goat antihuman 
IgG or IgM  (N.  L.  Cappel Laboratories, Inc.).  Radial immunodiffusion of antibodies with 
laminin was examined by Ouchterlony immunodiffusion at 4°C using 1% agarose by standard 
procedures. 
To  demonstrate  that  laminin  does  not  bind  nonspecifically to  other  IgG  molecules,  we 
preincubated two sera containing antinuelear antibodies (ANA) with 150 ~g/ml of laminin for 
1 h at 37°C and overnight at 4°C, before performing the immunofluorescent reaction. Nuclei 
of hepatocytes were used as antigen. 
Attachment Assays. The attachment to a  type IV collagen substrate of endothelial cells from 
sheep aorta, or of fibroblastic cells of the Chinese hamster ovary (CHO) line to plastic dishes, 
was  measured  in  the presence and  absence of sera or antibodies from  infected primates as 
previously described (9). 
Results 
Distribution of the Antigen.  In  preliminary studies, a  careful  analysis was  made  of 
the  histological  structures  that  were  stained  by  the  tissue-reacting  antibodies  in 
Chagas' patients and infected monkey sera. In general, they reacted in those areas of 
tissue where basement membranes were present. The pattern resembled that obtained 
when antibodies to isolated basement membrane components, such as laminin, were 
used  (8).  As  discussed  below,  the  tissue-reacting  antibodies  could  be  isolated  by 
laminin Sepharose affinity chromatography. 
The  reaction of antibodies from  infected monkeys purified by laminin-Sepharose 
affinity chromatography  (Fig.  1,  first  column)  was  compared  with  the  reaction  of 
rabbit  antilaminin  antibodies  (Fig.  1,  second  column).  Both  antibodies showed  an 
identical  and  intense  staining  of the  extracellular matrix  of the  EHS  tumor  (not 
shown), and of peripheral nerve in the perineurium, epineurium, and capillaries, and 1164  ANTIBODIES  TO  LAMININ IN CHAGAS' DISEASE 
Ftc.  1.  Comparison  by double  immunofluorescence histochemistry of the tissue distribution  of 
purified antibodies from monkeys infected with  T.  cruzi (first column) or from rabbits immunized 
with laminin (second column). Sections of mouse peripheral nerve (A and B), skin (C and D), kidney 
(E and F), and heart (G and H) are shown. 
a  less  intense  staining  of myelin  sheaths  (Fig.  1 A  and  B).  Differences  in  IF  were 
observed with other tissues. The  antibodies from  infected monkeys showed  a  broad 
distribution  along  the  epidermal-dermal junction  of skin,  including  the  epidermis 
(Fig.  1 C), whereas the antilaminin antibodies from rabbits showed a  linear distribu- 
tion  along the  epidermal-dermal junction  (Fig.  1 D).  In  the  kidney,  the  antibodies 
from  infected monkeys strongly stained peritubular capillaries, glomerular endothe- 
lium, and  mesangiat matrix;  but  reacted only very weakly with  the glomerular and SZARFMAN  ET  AL.  1 165 
tubular basement membranes and did not stain Bowman's capsule (Fig. 1 E), whereas 
rabbit antilaminin antibodies strongly stained all kidney basement membranes (Fig. 
1 F). In the heart, the antibodies from infected monkeys localized in the endocardium, 
vessels,  and  interstitium  in a  diffuse distribution  (Fig.  1 G) compared with the fine 
double line in certain regions with rabbit antilaminin antibodies (Fig.  1 H). 
Prior  treatment  of tissue sections with  chondroitinase ABC,  hyaluronidase,  and 
bacterial collagenase did not change the distribution or the intensity of the staining 
with antibodies from infected primates. The whole sera from monkeys and humans 
infected with  T.  cruzi  reacted  with  the same  histological structures as  the  purified 
antibodies  from  infected  monkeys.  Laminin  (25  #g/ml)  completely  blocked  the 
reaction while other purified connective tissue components (i.e., collagen types I, III, 
IV, and V, FN, BM-1 proteoglycan, or chondronectin) had no effect. 
Immunochernical Characterization.  ELISA assays indicated  that  sera from both acute 
and chronic patients contained antibodies to laminin and that the highest titers were 
present  in  the acute phase  (Table I).  No significant reaction of sera from patients 
infected with  T.  cruzi  was  observed with  type I,  III,  IV,  or V  collagen, FN,  BM-1 
proteoglycan, or chondronectin.  Sera  from the  various other healthy and  diseased 
humans or from uninfected monkeys did not react with tissues as judged by immu- 
nofluorescence and did not contain antibodies to laminin as judged by ELISA tests 
(titers ~:1:64). 
Monkeys and humans with acute T. crvzi infection had high titers (titers _>1:6000 
and ~ 1:1024, respectively) of IgM and IgG antibodies, which reacted with tissues and 
with  laminin.  The sera at  the chronic stage of the  infection had  no reacting IgM 
(_<I :2) and lower titers of IgG (I :500). The shift from IgM and IgG antibodies present 
TAaLE  I 
Immunofluorescence (IF) and ELISA  Titers for Antibodies to Connective Tissue Components in Sera  from 
Patients Infected with T~ypanosoma cruzi* 
Clinical stage  IF:~ 
ELISA 
Collagen type 
Laminin  b'N 
I  II1  IV  V 
BM-I Pro-  Chondro- 
teoglycan  nectin 
Chagas'  pa-  Acute 
tients  n =  6 
Chronic 
n-~9 
Controls  Normal 
from  en-  n-- 20 
demic area 
With  other  in- 
flammatory 
diseases 
n~  10 
~1024  --~4096  --<64  --<32 -<64  -<32  -<32  -<32  _<32 
(1024-8192) (4096- 
~512  ~51.2  -<64  --<32 -<64  -<32  -<32  -<32  -<32 
(s12-204e)  (512-2048) 
-<32  !  ----.32  N  -<64  -<32  -<32  --<32 -<32  -<32  -<32 
-<64  -<64  -<32  -<64  -<32  -<32  -<32  -<32  -<32 
Statistically significant values are italicized. 
* Goat anti-human IgG was used as a  second antibody. 
:~ Indirect  IF test  using heart,  skin,  and  EHS  tumor  cryostat  sections  as  antigens.  Each  serum  sample 
showed the same endpoint titer with all of the tissues studied. 
i~The numbers in parenthesis represent the range of values. 
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at  3  mo of infection to only IgG antibodies at  12  mo after infection in monkeys was 
verified with the purified antibodies by immunoelectrophoresis and  radial immuno- 
diffusion. 
Laminin  was  precipitated  from  solution  by  sheep  antilaminin  antibodies  or  by 
serum or antibodies purified from infected monkey serum. The presence of laminin in 
the precipitate was established by electrophoresis, based on the presence of two chains 
with  Mr  =  400,000  and  200,000  (Fig.  2).  In  addition,  purified antibodies obtained 
from  infected monkeys were found  to precipitate laminin in a  single line of identity 
with sheep antilaminin antibodies (data not shown). 
When  laminin  was  chromatographed  on  DEAE-cellulose under  dissociating con- 
ditions (8 M  urea), a  single peak was eluted (Fig. 3).  Electrophoresis of the fractions 
corresponding to  this  peak  revealed the characteristic chains  of laminin.  The  same 
peak contained  material that  reacted  in  ELISA tests with  the  serum  from  infected 
monkeys  and  sheep  antilaminin  antibodies  (Fig.  3),  the  purified  antibodies  from 
infected  monkeys,  or  serum  from  infected  humans  (not  shown).  No  reaction  was 
Fro. 2.  Gel electrophoresis of laminin  immunoprecipitated with  normal  sheep serum  (lane  1), 
normal monkey serum (lane 2), sheep antilaminin antiserum (lane 3), serum from a molakey  infected 
with  T.  cruzi  (lane 4), antibodies  purified by laminin  affinity chromatography  of 4 (lane 5), and 
unbound fraction after laminin affinity chromatography  of 4 (lane 6). Bands of Mr =  200,000 and 
400,000 correspond to laminin. 
Fro.  3.  Identification  of laminin  after  purification  by DEAE  cellulose chromatography.  Each 
fraction was subjected to sodium dodecyl sulfate gel electrophoresis (A) and was assayed for laminin 
by ELISA (B). Std., laminin standard. SZARFMAN  ET AL.  1167 
observed with  normal  monkey sera  (Fig.  3)  or with  the fraction of infected monkey 
serum not bound to laminin-Sepharose. 
The specific antigenic site that reacted with antibodies  from the infected monkeys 
and  sheep  antilaminin  antibodies  was  further  characterized  by testing  various  pro- 
tease-derived fragments of laminin in the ELISA assay. The antigenic activity of both 
antibodies  was  retained  in  the  PI  and  Pli  fragments  of laminin  (Mr  --  280,000) 
produced by digestion with pepsin;  however, when laminin was treated with Strepto- 
myces griseus protease  or trypsin,  its  reactivity  was  lost  (Table  II).  Laminin  did  not 
bind nonspecifically to other IgG molecules, because laminin did not block antinuclear 
antibodies  from binding to the nuclei of hepatocytes. 
Reaction  with  Parasites.  Antibodies  (both  the  IgM  and  IgG types)  from  infected 
monkeys,  purified  by  laminin-affinity  chromatography,  produced  a  very  strong 
reaction with trypomastigotes and amastigotes, but showed only a weak reaction with 
epimastigotes when used in the indirect IF technique. Laminin (25 #g/ml) completely 
blocked this reaction. In contrast, the antibodies present in the infected serum, which 
did not bind to the laminin affinity column and which did not stain tissues, intensely 
stained  the epimastigotes  and  amastigotes,  but  only weakly stained  the trypomasti- 
gotes. 
Functional Studies.  Laminin  is the attachment  protein  that  binds endothelial  cells 
to type IV collagen (9). Serum from infected monkeys (Fig. 4), as well as serum from 
Chagas'  patients,  similarly  inhibit  the  attachment  of endothelial  cells  to  type  IV 
collagen,  In addition,  purified  antibodies  from infected  monkeys (50 #g/ml)  inhibit 
the attachment of these cells. This inhibition was reversed by the addition of laminin 
to the medium in which the cells were suspended (Fig. 4). As expected, the attachment 
of CHO  fibroblasts, which is mediated  by FN, was not inhibited  by these antibodies 
(Fig. 5). 
Discussion 
Humans  and  monkeys infected  with  T.  cruzi produce  antibodies  that  react  with 
extracellular structures in some areas where basement membranes are present.  Their 
TABLE II 
Reaction of Laminin and Laminin Fragments with Antibodies Using the ELISA  Technique 
Substrate 
Antibodies purified by 
affinity chromatography 
to laminin 
Laminin-  T. cruzi- 
immunized  infected 
sheep*  monkey* 
Normal  Normal 
monkey  sheep 
serum:]:  serum::]: 
Laminin  1.2  I. 4  0.1  0.1 
Laminin plus trypsin  0.1  0. I  0. l  0.1 
Laminin plus S. griseus protease  0.1  0.1  0.1  0.1 
Laminin pepsin-derived fragments 
Pb  0.2  0.2  0.1  0.1 
Pc  0.1  0.2  0.1  0.1 
Pl  0.8  0.4  0.1  0.1 
Pli  0.8  0.8  0.1  0.1 
Detected with peroxidase-conjugated goat antihuman  IgG. 
significant values are italicized. 
* At a concentration of 50 #g/ml. 
~z Diluted 1:10. 
Absorbance was read at 492 nm. Statistically 1168  ANTIBODIES TO  LAMININ IN CHAGAS' DISEASE 
100 
8O 
Ncxm,  a~ 
~  MOnkey  Serum 
40  /  MOnkey  Serum 
20  Me  nlk~ect/~  mlnfected  ~+l~,glml Laminin 
0  --//  I  I  I  I  I 
0  "~0  -s  10  -4  10  -3  10  -2  10  -1 
Serum  Dilution 
FxG. 4.  Inhibition by monkey serum of attachment of endothelial cells to type IV collagen. The 
serum from an infected monkey inhibits the attachment to type IV collagen, and is reversed by 
added laminin. Normal monkey serum has no effect. 
100 
8O 
== 
E  6O 
"8 
20 
Infected 
Monkey  Serum 
Normal 
Monkey  Se~m 
__//  p  i  i  i  t 
0  10  -5  10  -4  10  -s  10  -2  10  -1 
Serum  Dilution 
FIo. 5.  Lack of inhibition by monkey serum of attachment of CHO cells. Serum from an infected 
monkey and normal monkey serum has no effect. 
sera were  found  to  contain  high  titers of antibodies to  laminin  but  not  to  various 
other connective tissue components. 
Several  different  tests were  used  to  confirm  the  identification of laminin  as  the 
tissue antigen. These studies included immunoprecipitation of laminin, absorption of 
the antibodies to laminin covalently bound to Sepharose beads, reaction of laminin 
with the antibodies in the Ouchterlony test, binding of antibodies to laminin-coated 
wells (the ELISA test), and inhibition of the attachment of endothelial and epithelial 
ceils (not shown). For preliminary studies using the ELISA technique, we have found 
that laminin obtained from human amnion is able to block the reactivity of laminin 
antibodies obtained from infected primates to laminin obtained from the EHS tumor 
(A. Szarfman, V. P. Terranova, and G. R. Martin, unpublished observation). The P1 
and Pli fragments of laminin produced by proteolytic digestion shows a  high degree 
of reaction with these antibodies. Furthermore, it is likely that laminin represents the 
major, or even  the only, tissue antigen  in  the  EVI  system, because passage of sera 
from Chagas' patients or infected monkeys over laminin-Sepharose beads eliminates 
the tissue reactions. 
Direct  comparison  of the  reaction  of these  antibodies with  rabbit  antibodies  to 
laminin in tissue sections revealed similar, but not identical, reactions. The antigen in 
tissues reacting with antibodies from infected monkey serum  is more labile than  the 
antigen  detected  by antilaminin  antibodies produced  in  rabbits  (data  not  shown). 
Furthermore,  rabbit  antilaminin  antibodies  stained  all  basement  membranes  uni- SZARFMAN ET AL.  1169 
formly, whereas the antibodies from infected primates showed a  more limited distri- 
bution. However, both sera stained the matrix of the EHS tumor, which is thought to 
be solely basement  membrane  (18).  It  is likely that  these two antibodies recognize 
different  antigenic  sites  in  laminin.  The  sheep  or  rabbit  antibodies  are  probably 
heterogeneous and directed against a variety of antigenic sites in the laminin molecule. 
The  antibodies  arising  after  T.  cruzi infection  may  recognize fewer and  different 
antigenic determinants in laminin. The interaction of laminin with other components 
of the  basement  membrane,  such  as  type  IV  collagen  and  the  heparan  sulfate 
proteoglycan, might mask some antigenic sites and make the protein unreactive with 
antibodies which recognize a  limited number of antigenic determinants.  Therefore, 
laminin may be a  heterogeneous family of proteins or could exist in several stages of 
processing which could affect the reactivity and specificity of the antigen. 
After infection by T. cruzi, antibodies are produced against laminin and not against 
any  of the  other  known  basement  membrane  or  connective  tissue  components. 
Furthermore, production of antibodies against  laminin  is a  distinctive feature of T. 
cruzi  infection  in  primates.  Such  antibodies  are  not  present  in  sera  from  normal 
individuals,  persons who have undergone surgery, or patients with  various inflam- 
matory  conditions  or  neoplasms,  malaria,  toxoplasmosis,  or  rheumatoid  arthritis. 
However, we  have  found  high  titers  of antibodies  to  laminin  in  Rhesus  monkeys 
infected with T~ypanosoma rhodesiense (A. Szarfman, K. Esser, V. P. Terranova, and G. 
R. Martin, unpublished observation). It is possible that the induction of antibodies to 
laminin is associated with trypanosomal infections. 
It  is  not  clear why  T.  cruzi infection induces antibodies  to laminin.  The titer of 
antibodies is highest during the early phase of the infection as would be expected if 
laminin or an immunologically related protein were produced by the parasite. In this 
regard, we have found that the trypomastigote and amastigote forms of the parasite 
have  a  higher reactivity with  purified antibodies  from  infected monkeys than  the 
epimastigote forms. Furthermore, recent studies have shown that sera from Chagas' 
patients increase the attachment and penetration of blood trypomastigotes into WI 
38 cells (24), and that purified antibodies to laminin decrease the penetration of the 
parasites (Dr. G. A. Schmufiis, personal communication). Because the trypomastigote 
form of T. cruzi encounters basement membranes during its penetration into the host, 
the production of a  laminin-like protein and or incorporation of host  laminin  may 
permit the parasite to interact with the host tissues. 
The significance of the antilaminin antibodies to the pathol6gy of Chagas' disease 
is unclear. As shown here, the antibodies in infected monkeys that react with laminin 
are able to block the attachment of endothelial cells to basement  membranes,  and 
this could damage blood vessels and endocardium leading to the endocardial fibrosis 
found in Chagas' disease (1) and in African Trypanosomiasis (25). The initial changes 
would arise during the parasitic invasion of the host, and the changes that occur later 
on would be part of a  slow destructive process secondary to autoimmune reactions 
(26,  27).  The study of the antilaminin antibodies that appear after infection with  T. 
cruzi holds considerable promise of yielding important information of the interactions 
of the parasite and it's host.  In addition, when immunization with  T. cruzi is taken 
into consideration, these antibodies can become useful in producing antigenic prep- 
arations of T. cruzi, void of host tissue components. 1170  ANTIBODIES  TO  LAMININ IN CHAGAS' DISEASE 
Summary 
We have found that sera from humans with Chagas' disease and Rhesus monkeys 
infected with  Trypanosoma  cruzi  contain  IgM  and  IgG  antibodies,  which  react  with 
structures in a  variety of connective tissues. These antibodies react with laminin but 
not with various other purified connective tissue components like collagen types I, III, 
IV, and V, fibronectin, heparan sulfate (BM-1)  proteoglycan, or chondronectin. The 
tissue-reacting antibodies were isolated by absorption to a laminin-Sepharose column. 
The  bound  fraction  contained  all  the  tissue-reacting antibodies.  These  antibodies 
strongly stained trypomastigotes and amastigotes, but weakly stained epimastigotes. 
These  studies  show  that  sera  from  T.  cruzi-infected  primates  contain  antilaminin 
antibodies,  which  may  be  produced  by  those  host  in  response  to  a  laminin-like 
molecule present in the parasite. 
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